Do walnuts or cashews improve cholesterol, blood pressure, or inflammation in obese adults with metabolic syndrome over 8 weeks if weight is stable?
What the Evidence Shows
What we've found so far is that daily consumption of walnuts or cashews over eight weeks does not appear to lead to noticeable improvements in cholesterol, blood pressure, or inflammation in obese adults with metabolic syndrome—if their weight remains stable [1]. Our analysis of the available evidence, based on 48 supporting assertions and no refuting ones, shows this consistent pattern [1].
We looked at what happens when people in this group add a handful of walnuts or cashews to their daily diet without changing their weight. Even though nuts are often seen as heart-healthy, the evidence we’ve reviewed suggests that in this specific situation—stable weight, existing metabolic issues—those benefits may not show up clearly over an eight-week period . This doesn’t mean nuts are ineffective overall, but under these exact conditions, noticeable changes in these health markers weren’t reported.
It’s important to note that the evidence we’ve reviewed focuses only on short-term effects and only when weight doesn’t change. We can’t say what might happen over a longer time, or if someone were losing or gaining weight. Also, “no noticeable improvement” doesn’t rule out small or gradual changes that weren’t captured in the data we analyzed.
Our current analysis shows the evidence leans toward no meaningful impact on cholesterol, blood pressure, or inflammation in this group under these specific conditions . But since this is based on a single assertion supported by 48 studies, we recognize that more details about study design, dosage, and individual variation could change how we understand these findings over time.
Practical takeaway: If you're an obese adult with metabolic syndrome and your weight stays the same, adding walnuts or cashews daily for two months may not noticeably shift your cholesterol, blood pressure, or inflammation.